Multivariate analysis showed that FLI-1 was also an independent prognosticator for poor OS and DMFS. Incorporation FLI-1 with clinical stage enabled accurate stratification of NPC patients into four subgroups with different risk levels of death, distant metastasis and progression in the training, testing and whole set. Before FLI-1 is eventually applied in clinical practice, the mechanism by which FLI-1 is involved in the carcinogenesis and progression of NPC should be clarified and all results

need to be replicated in a different NPC population. Wuguo Deng and Fangyun Xie both designed the study and help to draft the Ulixertinib in vivo manuscript. Xuexia Liang and Dingbo Shi carried out the immunohistochemical staining work and interpreted the data. Xuexia Liang analyzed the data and drafted the manuscript. Xuexia Liang, Yanping Mao, Jingping Yun, Puyun Ouyang and Zhen Su collected the data. Jia Fu and Jinghui Hou evaluated the immunohistochemical staining. All authors read and approved the final manuscript. This work was supported by grants from the National Natural Science Foundation

of China (81272195, 81071687, 81372133), the State “863 Program” of China (SS2012AA020403), the State “973 Program” of China (2014CB542005), and the State Key Laboratory of Oncology in South China. “
“Hepatitis C virus (HCV) infection is one of the major public health problems worldwide [1]. Chronic HCV infection is characterized by a high rate of progression to fibrosis, chronic hepatitis, leading

to cirrhosis and ultimately to hepatocellular carcinoma (HCC) [2], [3] and [4]. Although the KU-57788 purchase relationship between HCV and the development of HCC is well established, the pathogenetic mechanism of hepatocarcinogenesis, including host- and viral-related factors, is still unknown. It is prudent to affirm that differences in the incidence Vorinostat order rates and the strong gender distribution in HCC are not entirely due to differences in the exposure to the causative agents [5] and [6]. Of great importance, genetic factors can also contribute, particularly gene polymorphisms of inflammatory cytokines and growth factor ligands and receptors [7]. Vitamin D is involved in the metabolism of skeleton as a systemic hormone but also has important roles in the regulation of host immune responses, fibrogenesis and development of cancer through vitamin D receptor (VDR) [8], [9], [10], [11], [12], [13] and [14]. Previous data have suggested that vitamin D levels may influence cancer development. In particular, several single nucleotide polymorphisms have been described in the VDR gene, and some polymorphisms are associated with tumor occurrence [12], [13], [14], [15] and [16]. For instance, VDR polymorphisms have been related to cancers of the breast, prostate, skin, colon-rectum, bladder and kidney, although with conflicting observations [12], [13], [14], [15] and [16].